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Introduction
The mediastinum is an extremely important and complex part of
the  thorax  because  it  contains  a  variety  of  important  organs  and
anatomic structures. Many histologically different neoplasms and cysts
that affect people of all ages arise from the multiple anatomic structures
present  in  the  mediastinum.Because  this  area  is   also   the  site   of
numerous lymph nodes, metastases  secondary to lesions in other parts
of  the  body  are  also  frequently  found.  Both  benign  and  malignant
lesions are   being recognized with   increasing   frequency, and   a
differential diagnosis is important whenever possible.  The  incidence
and types of the many primary mediastinal tumors and cysts vary with
the  age  of  the  patient   group   under  consideration.   In   infants  and
children, neurogenic  tumors  are the most  common,  followed by
lymphomas,  foregut  cysts,  and  benign  germ  cell  tumors.  In  adults,
thymic  tumors  are  the  most  common  surgically  treated  mediastinal
tumors. Treatment strategies for mediastinal tumors and cysts are quite
broad, depending on the nature of the disease (1).
Major changes    have recently    occurred in    the    clinical
presentation,  diagnosis,  and  management  of  primary  lesions  of  the
mediastinum.  New diagnostic techniques and  improved  therapy have
led to more objective preoperative diagnoses as well as better longterm
results.
Mediastinal masses are the lesions in the thoracic space bounded
superiorly by the thoracic inlet; inferiorly by the diaphragm , anteriorly
by the sternum posteriorly by the spine, laterally bounded by the pleural
spaces, including the mediastinal pleura.
Review of
Literature
ANATOMICAL PERSPECTIVES:
The mediastinum  is strategically  located from  the thoracic inlet
to the diaphragm between the left and right pleural cavities and contains
vital  structures of  the circulatory, respiratory, digestive  and  nervous
systems.  Embryologic  development  leads  to  cells  from  ectodermal,
mesodermal  and  endodermal  origin  ultimately  residing  in  the  small
mediastinal compartment.  Clinically the  mediastinum  may be divided
into superior and inferior compartments with the  inferior mediastinum
being  subdivided  into  anterior,  middle  and  posterior  sections.  The
topographic landmarks in each division  of  the mediastinum  allow for
directed investigative, diagnostic and therapeutic strategies (2) .
The mediastinum (from the Greek medium istemi) is an anatomic
region localized  at the center  of the  thorax, limited in  front by  the
sternum, in the back by the spine and laterally by the lungs with their
pleural lining.  There are  several classifications  for the mediastinum,
although it is Shield who classically divided this region into three areas:
anterior, visceral and posterior limited  by two frontal planes. The first
tangent to the anterior surface of the pericardium and the large vessels,
the  second  tangent  to  the  anterior  surface  of  the  vertebral  bodies.
Thymus   is  found  in  the anterior  mediastinum with  the internal
mammary  vessels,  the lymph nodes,  connective tissue,  fat-cell  tissue,
the lower pole of thyroid and the ectopic parathyroids.
In the visceral compartment there are the heart and pericardium
the great vessels ascending, and descending aorta, the aortic arch with
the supraortic vessels, the pulmonary artery with the proximal segment
of  their  branches,  the  distal  segments  of  the  pulmonary  veins,  the
superior  vena cava with the  brachiocephalic trunks,  the azygos vein,
and  Botallo’s  ligament or Botallo’s pervious  duct the thoracic duct
nerves: vagus, phrenic, recurrent laryngeal, lymph node chains and the
anterior surface of the vertebral bodies.
In the posterior compartment there are the lateral  surface of  the
vertebral bodies, the internal surface of the  intercostal muscles, the
proximal segment of the intercostal nerves, the sympathetic chain with
its  ganglions and  hemiazygos vein. The wide  variety of mediastinal
masses  different for embryological  origin,  anatomic  constitution,
location and functional features  are  responsible  for the various signs
and symptoms which are collectively called the mediastinal syndrome,
which are due  to compression,  obstruction or infiltration of the mass
over  near structures.  The  mediastinal  syndrome  includes  all
the symptoms caused by  the pathological  environment of  all
mediastinal
structures and  systems, the  cardiovascular, respiratory, digestive and
lastly  the   peripheral  and   central  nervous  system.  It  can  be   total,
affecting  all three  compartments or partial,  with anterior,  median or
posterior mediastinal syndrome. In addition, it is important to mention
systemic syndromes associated with tumoral masses and syndromes of
endocrinal hypersecretion caused by tumors.

ANTERIOR MEDIASTINAL TUMORS:
· Thymic tumors
· Lymphoma
· Germ Cell Tumors
· Endocrine tumors
· Mesenchymal tumors
THYMIC TUMORS :
· Incidence – 15 per 1 lakh per person per year
· 50% of anterior mediastinal tumors
· 30% in adults and 15% in children
· Various lesions
o Thymic Hyperplasia
o Thymoma
o Thymic cyst
o Thymolipoma
o Thymic Carcinoma
o Thymic Neuroendocrine tumors
· Developed as pairs  of epithelial anlagen in ventral  portion of
third pharyngeal pouch.
· Histology
o 6 types  - 4 in cortex , 2 in medulla
o Type 6 cells are called Hassals Corpuscles
Classification of thymic tumors
· Rosal and Levine Classification
· Marino and Muller Hermeling
· WHO Staging
· Masoaka staging – provides    more precious prognostic
information
Associated diseases
· Myasthenia
· Cytopenia
· SLE, RA, Polymyositis.
MYASTHENIA GRAVIS:
Most common associated  disease  with  thymoma  is  myasthenia
gravis, 5 to 15 % of myasthenia gravis are found to have thymomas. 30
to 50  % of  thymomas are associated  with clinical  myasthenia gravis
The disease may develop later even after thymectomy, for this reason it
is  essential  that  complete  thymectomy  be  performed  as  a  part  of
resection  of  any  anterior  mediastinal  tuimors  that  may  present  as
thymoma.
GERM CELL TUMORS:
Anterior mediastinum is the most   common location   for
occurence of extra gonadal germ cell tumors accounting for 15 to 20%
of all anterior mediastinal masses.
· Benign mediastinal teratoma
Accounts   for   60%  of  mediatinal  germ   cell   tumors  Usually
asymptomatic in adults
Presents in children due to airway compression
· Malignant mediastinal teratoma
Seminomatous – 40%
Non seminomatous – 60 % - Embryonal cell carcinoma
- Choriocarcinoma
- Yolkm Sac tumor
- Teratocarcinoma
These generally present as diffuse non discrete anterior
mediastinal masses.  Serum  levels of  AFP ,  B-HCG  , LDH may be
helpful.
MIDDLE MEDIASTINAL TUMORS
· Cysts
· Lymphomas
· Mesenchymal tumors
· Carcinoma
LYMPHOMAS:
The    mediastinum is    commonly    involved    by    malignant
lymphomas.  Most  mediastinal  lymphomas  occur  in  the  anterior  or
middle mediastinal compartments. They usually arise from mediastinal
lymph nodes but may arise from the thymus gland or other mediastinal
structures. About 50% of Hodgkin’s disease and 20% of non-Hodgkin’s
lymphomas present as mediastinal lymphomas.  The  size  of  the mass
dictates  whether  symptoms  are  present.  Bulky  mediastinal  disease
usually  causes compression  symptoms. Patients commonly have  chest
pain  or heaviness and  cough. Dyspnea may  result from  large airway
compression, lung compression, pleural effusion or pericardial effusion.
Due to the right sided predominance of paratracheal lymph nodes, SVC
syndrome is relatively  common (20–60%  of  patients), especially  in
those with non-Hodgkin’s lymphoma. Diagnosis of Hodgkins is proven
by  the  presence  of  Reed  Sternberg  cells.  Management  is  basically
chemotherapy / radiotherapy.
CYSTIC LESIONS
20% of all   mediastinal masses.   Common   in   the   middle
mediastinum and rarely in the posterior mediastinum which comprises
of
· Bronchogenic cyst
· Hydatid cyst
· Enteric cysts
· Intramural esophageal
· Neuro enteric cysts
Bronchogenic cysts : 60  % of  mediatinal  cysts. Part of  spectrum  of
broncho pulmonary   foregut abnormalities including  extralobar,
intralobar     sequestration and  congenital     cystic adenomatoid
malformation. Presents as  chest  pain , cough, hemoptysis.  The cyst  is
lined  by  ciliated  columnar  epithelium  and  excision  in  toto  is  the
treatment of choice.
Gastroenteric  sycts  :  These  are  duplication  cysts,  which  are  peri
esophageal   lesions  that   form  from   posterior   division  of  primitive
foregut. May arise  in  middle or posterior mediastinum  lined  by  non
keratinizing  squamous  ciliated  columnar  gastric  or  small  intestinal
epithelium. Presents as cough or dyspnoea, excision is the treatment.
Neuroenteric  cysts: Develops  because  of  failure  of   separation  of
notochord  form  primitive gut. Presents  in  infants  less than 1 year of
age.  It  is  connected  to  meninges.  Possess endodermal or ectodermal
neurogenic  element. Associated  with  scoliosis ,  hemivertebrae, spina
bifida. Excision is the treatment of choice.
OTHER MEDIASTINAL TUMORS
· Amyloid masses
· Castleman’s disease
· Chordomas
· Fibromas
· Mesotheliomas
· Rhabdomyosarcomas
· Myxomas
· Hemangiomas
· Lymphangiomas
CLINICAL FEATURES
· 40% are asymptomatic . Detected incidentally by routine chest x-
ray.
· 60% are symptomatic. Symptoms may be due to
§ Compression – cough, dyspnoea, stridor.
§ Invasion – pain, hoarseness, Horner’s syndrome
§ Paraneoplastic syndromes
§ Haemoptysis
· Asymptomatic patients usually present with benign lesions while
symptomatic likely to have malignant disease.
THYMOMAS
- anterior mediastinum
- cough, dyspnoea, hoarseness of voice
- myasthenia gravis
GERM CELL TUMOR
- anterior mediastinum
- chest pain, dyspnoea, cough ,fever
NEUROGENIC TUMORS
- posterior mediastinum
- pain,   paeresthesia,   Horner’s   syndrome,   muscular   atrophy,
SVC syndrome.
- In infants and children the tumor is malignant , where as
- benign in adults
LYMPHOMAS
- Middle, posterior mediastinum
- Presents as cough, fever, dyspnea, mass
- SVC syndrome (right sided NHL)
CYSTIC LESIONS
- Middle, posterior mediastinum
- Usually asymptomatic
- Occassionally presents as cough, pain, compressive
symptom.
Endocrine  hypersecretion  syndromes  associated  with  mediastinal
masses (3)
S. Cushing Thymoma
Gynecomastia Germ-cell tumor
HCG increase Germ-cell tumor
Leyding’s cell stimulation Germ-cell tumor
Arterial hypertension Pheochromocytoma
Diarrhea Ganglioneuroma
Ganglioneuroblastoma
Neuroblastoma
Hypercalcemia Lymphoma
Hypoglycemia Teratoma
Fibrosarcoma
Neurosarcoma
EVALUATION OF MEDIASTINAL MASSES
History and Physical Examination
Chest Radiograph (Posteroanterior and Lateral)
Mediastinal Mass
CT Scan of Thorax
MRI (If indicated)
Angiography (If indicated)
ENDOSCOPY (If indicated)
Suspect Mediastinal Tumor
Biopsy Surgery
1.  Scalene node 1. Median Sternotomy
2.  Mediastinoscopy 2. Lateral Thoracotomy
3.  Fine needle aspiration
4.  FOB
Mediastinal    tumours    have  similarities in    presentation,
investigation  and surgical  approach   depending  on  the  anatomical
compartment in which they arise. The anterior compartment is bordered
by the   sternum anteriorly,   the   pericardium   posteriorly   and   the
mediastinal   pleura laterally. The main   structure  in the anterior
compartment is the thymus,  though retrosternal thyroid  or  parathyroid
tumours as well as germ cell, lymphoma and rare vascular tumours also
occur  there.  The  usual  surgical  approach  is  via  median  sternotomy
though unilateral disease  or  the presence  of  associated pleural disease
may be better approached by a lateral thoracotomy.
The visceral (middle)    compartment,    from the    anterior
pericardium  back  to  the  pre-vertebral  fascia  and  bounded  by  both
pleura, includes the heart, trachea, main bronchi and oesophagus.
The posterior compartment, better referred to as the paravertebral
sulci, includes those  structures medial to the pleura but excluding the
vertebral column. The common tumors in this area are the neurogenic
tumours  arising  from  intercostal  nerves  and  the  sympathetic  chain.
Though  such  tumours  arise  in  the  posterior  mediastinum  they  can
encircle vital structures   of the   visceral compartment   preventing
complete excision. Cartilage and bone tumours of the necks of the ribs
can mimic posterior mediastinal tumours. The surgical approach to the
posterior mediastinum  is via posterior thoracotomy with paravertebral
extension where a tumour permeates through an intervertebral foramen.
Presentation
Mediastinal  tumours in children are usually symptomatic  with
respiratory  symptoms such  as cough,  stridor  and  dyspnoe.  Malignant
lesions are often accompanied by lethargy, fever,  malaise and  chest
pain.  In  adults many lesions are  asymptomatic,  found  incidentally on
routine chest radiographs. However,  obstructive  symptoms do occur
when the tumour compresses on the superior vena cava, oesophagus or
tracheo-bronchial tree and  cardiac tamponade can be caused  by  large
anterior compartment tumours. Invasion of phrenic, recurrent laryngeal
or    sympathetic    chain    nerves may    also    cause    symptoms of
breathlessness, hoarseness or Horner’s syndrome respectively.
Diagnosis
Imaging of the mediastinum is crucial in distinguishing tumours
from   other benign   cystic  lesions (thymic,   bronchogenic, enteric
duplication,   neuroenteric, mesothelial and cystic   hygroma) and
granulomatous lesions (sarcoidosis, histoplasmosis and tuberculosis).
A CT scan or MRI scan will outline the exact site of the lesion
and will give clues to the diagnosis, a variegated appearance suggesting
teratoma. These scans will also give an indication of malignant invasion
of  adjacent  structures  and  pleural  metastases  which  in  the  case  of
thymoma produce a "droplet" pattern.
Fine   needle   aspiration   cytology   is   frequently  inadequate   to
differentiate  thymoma  from  lymphoma  and  almost  never  provides
enough tissue to differentiate between types of lymphoma, an important
consideration, as Hodgkin’s and non-Hodgkin’s lymphoma are treated
by different modalities in the first instance. A core biopsy is sometimes
safe  and productive though  the proximity of the  aorta  and  other great
vessels dissuades some radiologists. Mediastinoscopy, mediastinotomy
via  anterior  mini-thoracotomy  or  thoracoscopy  may  be  required  to
provide enough tissue for the pathologist to  make a full diagnosis.  In
patients who are unstable due to compression or obstruction of a vital
organ treatment with steroids, radiotherapy or chemotherapy may need
to be commenced before a full diagnosis is obtained surgically.
Thymic tumours are  unique in that they  are associated  with a
number   of   paraneoplastic or "parathymic"   syndromes.   The rare
paraganglionic neurogenic tumours  may be also be functional in that
they   produce   biogenic   amines.   In   this   regard they   resemble
phaeochromocytoma. Vanillylmandelic acid or  homovanillic acid may
be  detectable  in  the  urine.  Haematological  markers  of  germ   cell
tumours (beta-HCG  and  alpha  feto-protein)  should  be sought. Both
markers are negative in benign teratoma but both tend to be elevated in
malignant non seminomatous tumours. The beta hCG may be elevated
in seminoma but the presence of an elevated alpha feto-protein suggests
that there are non seminomatous elements which need  to be treated as
such.

Systemic syndromes associated with mediastinal masses
Myasthenia gravis Thymoma
Hypogammaglobulinemia Thymoma
Systemic lupus erythematosus Thymoma
Scleroderma                                                Thymoma
Fever of unknown origin Lymphoma
Claude Bernard–Horner Neuroblastoma
Parfour-Depetit Neuroblastoma
Opsoclonus-myoclonus Neuroblastoma
Vertebral anomalies Intestinal duplications
INVESTIGATIONS (1)
When a mediastinal lesion is recognized on standard radiographs
of the chest, the diagnostic possibilities can be narrowed to a reasonable
number by considering the patient’s age, the location of the mass, and
the associated symptoms and signs present. At first, a careful evaluation
of   the  history   signs,  and   symptoms  is  valuable.  Various  imaging
modalities are currently available and provide excellent depiction of the
mediastinal  lesions.  The  main  imaging  modalities  used   are  chest
radiography, CT, MRI, and positron emission tomography (PET).
CT is routinely indicated  when a  mediastinal lesion is detected
by chest radiography. The rapid acquisition of the entire thorax during a
single  breath-hold   minimizes  motion  artifacts  and   allows  optimal
vascular contrast enhancement (1). It allows a reliable evaluation of the
mediastinal anatomy and the  relationship of  the lesions with adjacent
structures.  CT is a  sensitive method  of distinguishing between fatty,
vascular, cystic, and soft tissue masses. However, the differentiation of
a cyst and a solid tumor is not always accurate  (2). MRI may supply
additional useful information in  separating  mediastinal tumors  from
vessels and  bronchi, especially when  the  use  of contrast  material is
contraindicated.  MRI  is  more  accurate  than  CT  in  assessing  tumor
invasion to the great vessels, heart, and chest wall, and in distinguishing
a cyst from a solid tumor (3,4). T1-weighted images are most valuable
in   anatomic assessment, whereas T2-weighted images   are   most
valuable in tissue characterization. A cyst has homogeneous high-signal
intensity  on the  T2-weighted  image  and  can be  distinguished  from  a
solid  tumor.  PET  using  fluorine-18  fluorodeoxyglucose  (FDG)  has
emerged as a diagnostic tool  for  staging several  types of neoplasms.
Fusion  of  FDG-PET  with  CT  images (PET/CT) further  increases the
diagnostic accuracy  by  depicting more precisely the anatomic  site  of
uptake and avoiding misinterpretation of normal hypermetabolic area as
disease.
FDG-PET is useful in differentiating thymoma from hyperplasia
in myasthenia gravis, (5) and may be useful for predicting the grade of
malignancy in thymic epithelial tumors (6). Radioisotope scanning has
been  of  specific  aid  in establishing  a  definitive  diagnosis for  ectopic
thyroid  and  parathyroid  tumors.  Biochemical  makers  and  elevated
hormone levels are present in patients with various mediastinal tumors.
Infants and children with a paravertebral mass should be evaluated for
excessive norepinephrine and  epinephrine production.  This increased
production  is  present  in  association  with  most  neuroblastomas  and
ganglioneuroblastomas. Young adult men with an anterior mediastinal
mass should have determinations of levels of ?-fetoprotein and b-hCG.
Either one or both are elevated  in the presence of a nonseminomatous
germ cell   tumor.  Antiacetylcholine   receptor  antibodies   should  be
measured  in patients with thymoma because  occult  myasthenia  gravis
may be  found. Serum-soluble  interleukin-2  receptors may be elevated
in the  presence of mediastinal lymphoma. Hypokalemia,  high-serum
cortisol,  and  adrenocorticotropic  hormone (ACTH)  levels  are  seen  in
some  patients with  thymic carcinoid  tumors that  produce an ectopic
secretion of ACTH.
METHODS FOR PATHOLOGIC DIAGNOSIS (1)
A  variety  of  biopsy  techniques  for  obtaining  tissue  from  the
mediastinum have   been   described,  including   ultrasound   guided
endoscopic    biopsy,    percutaneous image-guided needle    biopsy,
parasternal anterior  mediastinotomy,  cervical  mediastinoscopy,  video-
assisted thoracoscopic surgery and open surgical procedures.
Percutaneous US-Guided Needle Biopsy:
Ultrasonography   is  an   effective   modality   for   guidance   of
percutaneous biopsy.  Compared  with CT,  US-guided biopsy offers a
number of advantages including bedside  approach,  lower  cost, lack of
radiation exposure, and real-time monitoring  (7). With real-time
monitoring by means of US guidance, the tip of the biopsy-needle can
be  monitored  throughout  the  procedure. Another great  advantage  of
US-guided biopsy is that it can approach the lesion from any direction.
This  advantage  allows  biopsy  of  an  upper  mediastinal  lesion  via  a
supraclavicular approach . CT-guided biopsy of  this region is usually
hindered by surrounding bony structures at an axial plane. On the other
hand,  the  greatest limitation of USguided  biopsy  is that  its clinical
application  for  thoracic  lesions  is  generally  confined  to  anterior  or
posterior mediastinal tumors that are in contact with the chest wall. The
USG  units equipped  with Doppler US may be preferable, as Doppler
USG  can be used  to  detect  vessels and  blood  flow that  should be
avoided from  the  biopsy  root.  After confirming  the  biopsy  root,  the
USG  probe  is  equipped  with  a  sterile  puncture  transducer  with  a
guiding channel. If the lesion is less than 20 mm to 22 mm in diameter,
the tip  of  the needle should be placed  at least 20  mm  away from  the
posterior margin of the lesion. To reduce the false-negative rate, having
a cytologist present during biopsy has been advocated.
Percutaneous CT-Guided Needle Biopsy
This procedure   is   performed percutaneously under   CT-
fluoroscopic guidance.9 Before the procedure, CT images are obtained
for  targeting  the  lesion.  The   needle  path  is  determined,  avoiding
interlobular  fissures, visible  bronchi,  and relatively  large  vessels.  The
needle path may  be  through the lung , a  route that  cannot be used in
US-guided  biopsy.  After  the  administration  of  local  anesthesia,  the
introducer needle is advanced along the determined path until its tip is
in front  of the  lesion.  Acquisition of a specimen  is  repeated  until the
specimens obtained  are considered  adequate for histologic evaluation.
Chest CT images are  obtained  to  evaluate  procedural  complications.
Pneumothorax (8%–61%) is   the   most commonly   encountered
complication after USG guided or CT guided  needle biopsy, followed
by hemoptysis (1.6%–3%).
USG-Guided Endoscopic Biopsy
Endobronchial  ultrasound  ,  first  introduced  during  the   early
1990s,  has emerged as a new diagnostic tool that allows visualization
beyond  the  airway.10 Because  of  the  development  of  miniaturized
radial probes with flexible catheters having a balloon at the tip (Fig. 6),
bronchoscopists  can  perform  real-time  EBUS-guided  transbronchial
needle  aspiration  (EBUS-TBNA).  Although  EBUSTBNA  is  mainly
used  for lymph  node staging in lung  cancer, it can also  be  used  for
tissue  diagnosis for middle mediastinal lesions.  A 22-gauge  needle is
passed through the airway wall and inserted into the lesion under real-
time  ultrasound  control.  Esophageal US-guided  fine-needle  aspiration
needle biopsy is sometimes indicated  for  the posterior- and  inferior-
mediastinal lesions.  EBUS-TBNA is minimally invasive and  can be
performed  quite  safely under local  anesthesia.  The  disadvantages  are
that the tissue sample is  small, the procedure is  time-consuming and
technically demanding, and  it requires expensive  tools.  It  is for  these
reasons that this procedure can be performed only in some centers.
Parasternal Anterior Mediastinotomy
When   needle   biopsy   has   failed, many   surgeons   prefer
Chamberlain’s approach:11 an open biopsy using a parasternal anterior
mediastinotomy.  The  patient is placed  under general anesthesia in a
supine position. Local anesthesia is occasionally used. A 3-cm to 4-cm
transverse  parasternal skin  incision is made  at the desired  intercostal
space, depending on  the  location of  the  tumor.  Great care should  be
taken to stay lateral  to  the  internal mammary vessels. Under direct
visualization between the ribs and using biopsy forceps, an adequately
sized  specimen can be obtained from  an anterior  mediastinal  tumor.
Para-aortic lesions  and masses  arising from the aortopulmonary
window can be reached by inserting a  mediastinoscope through the
parasternal incision.
Mediastinoscopy
Conventional  mediastinoscopy   and   recently   developed   video
mediastinoscopy  are  generally  used  for  evaluating  the  mediastinal
lymph nodes in patients with carcinoma of the lung. These techniques
are also  useful for the diagnosis of mediastinal  lesions  located  in the
pretracheal, paratracheal, and subcarinal spaces.12 Under  general
anesthesia, a  small transverse incision is made  2 cm above the sternal
notch.  The pretracheal fascia is incised  and a tunnel created by gentle
finger dissection along the anterior and lateral walls of the trachea in to
the mediastinum. The mediastinoscope is then introduced and advanced
further   by means   of   blunt instrument dissection   to extend the
mediastinal tunnel. Great care should be taken to avoid vascular injury
and left-recurrent nerve palsy. An adequately sized tissue sample can be
obtained using biopsy forceps.
Video-Assisted Thoracoscopic Surgery
Video-assisted  thoracoscopic  surgery (VATS)  has  been widely
used for various types of thoracic surgery. Under general anesthesia, the
patient is intubated with a double-lumen endotracheal tube and placed
in  a  lateral  decubitus  position.  With  the  lung  collapsed,  the  entire
thoracic cavity is visible. VATS is a valuable procedure,  especially in
cases of lesions with difficult access that require direct vision, such as
tumors close to  great vessels or the heart.13,14 The  disadvantage  of
VATS biopsy for  mediastinal tumor is possible tumor seeding to  the
thoracic cavity by opening the pleura.
DECISION-MAKING
One  can  make  a  reasonable  preoperative  diagnosis  for  each
lesion  by  considering  the  age  of  the  patient, location,  the presence  or
absence of symptoms and signs,  the association of  a specific systemic
disease,  radiographic  findings,  and biochemical markers.  The decision
about  how  to manage a  mediastinal tumor  could be made  by
observation,   surgical resection, chemotherapy, radiotherapy, or
multimodality therapy depending on the nature of the disease. Since the
introduction of VATS, the threshold for surgical resection of the lesion
has  been  lowered.  In  most  patients  with  cystic  lesions  or  probable
benign  solid  tumors,  such  as  neurogenic  tumors  in  adults,  VATS
extirpation of  the lesion  is recommended  without  biopsy,  being  both
diagnostic  and  therapeutic  simultaneously.  When  radiographs  show
typical signs of  benign germ  cell tumors, mature teratomas,  or  early
stage  thymomas,  it  is  recommended   for  open  or  VATS  resection
without biopsy.  It is much more  difficult to  make a precise diagnosis
for poorly demarcated  tumors in the  anterior or  middle mediastinum.
Thymomas, thymic  carcinomas,  seminomas,  nonseminomatous germ
cell   tumors, and lymphomas   are   quite   similar   in  radiographic
appearance  but  are  quite  different  in  treatment  strategy.  Therefore,
pathologic  diagnosis is required to  select  the  optimal  treatment
modality.  Several  techniques  and  approaches  have  been  previously
described and are available to obtain specimens of mediastinal tumors.
The choice of technique depends on the location of the lesion, clinical
factors such as the age and condition of the patient, and the availability
of   special   techniques  with   the   required   expert  and   the  necessary
equipment.  In  general,  percutaneous  biopsy  is  the  first  diagnostic
choice because it can be done under local anesthesia.
Aims & Objectives
Retrospective nonrandomized observational study to  review and
analyze  the  experience  in  diagnosis  and  surgical  management  with
emphasis on the evolution of surgical techniques at our institution in the
treatment of Mediastinal Masses.
Materials and Methods
71 consecutive patients diagnosed with mediastinal  masses
admitted  in the Department of Cardiovascular and  Thoracic surgery,
Madras Medical College, Chennai, between  September 2006  to  April
2009 comprised the sample for this study. Case sheets of patients were
obtained  from  Medical  Record Department  for  analysis.  A detailed
clinical examination and findings were recorded over structured
proforma (Annexure) for all patients.
All patients under this study are classified according to their age,
sex,  mode  of  presentation, method  of diagnosis,  site of  the  tumour,
surgical approach and postoperative morbidity, mortality work up.
All  patients were assessed  and  taken up  for surgery. Under GA
using   double   lumen ETT,   patients   were   subjected   for   surgical
procedure.  Depending  on  the  location  and  diagnosis,  the  necessary
surgical  procedure  performed.  Surgery  was  either  incision  biopsy,
excision biopsy or debulking based on the tumor and sent for HPE.
Post   operative   biopsy results were analysed compared and
confirmed.  Necessary  patients  were  either  referred  to  chemotherapy,
radiotherapy or discharged home.
Observations and Results
AGE DISTRIBUTION OF THE STUDY POPULATION
Age group Total No: of cases
10-19 years 14
20-29 years 17
30-39 years 20
40-49 years 10
50-59 years 7
60-69 years 1
70-79 years 2
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The  total  number  of  patients  in  this  study  is  71  patients.  On
classifying the age distribution of the study population, it was observed
that the majority of the patients belonged  to  the 30  to 39 year age
group, forming about 28.27% of the total number of patients. The next
to follow are the 20  to 29 years age group forming about 23.94%.The
least number of patients was found in the 60 to 69 year age group.
SEX DISTRIBUTION
Age group Males Females
10-19 6 8
20-29 10 7
30-39 12 7
40-49 4 7
50-59 5 2
60-69 0 1
70-79 2 0
Total 39 32
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On  calculating the age  wise  sex  distribution,  it was noted  that
males formed 54.93%  of  the  total,  female  patients forming 45.07%.
Male preponderance was noted  in th  20  to  39  age distribution, while
females outnumbered male patients in the 10 to 19 age group and 40 to
49 age groups.
SYMPTOMS
Symptoms No. of cases
Cough 26
Pain 13
Dyspnoea 4
Stridor 0
Dysphagia 2
Haemoptysis 7
Myasthenia 8
Others 1
Asymptomatic 27
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Of the total number patients, 52 of them presented
symptomatically while, 27 patients were asymptomatic at presentation
and  diagnosis  was coincidental.  Of the presenting  symptoms, cough
was  the  major  symptom  ,   seen  in  36.62%  of  patients.The   other
presenting  symptoms   were pain   (   18.31%), dyspnoea (   5.6%),
Hemoptysis ( 9.8%) and dysphagia (2.8%).
LOCATION OF TUMOURS
Location No: of Cases
Anterior Mediastinum 25
Posterior Mediastinum 25
Superior Mediastinum 6
Middle Mediastinum 15
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Majority  of  the  cases  were  seen  in  the  anterior  and  posterior
mediastinum,  50  patients out of  71  patients,  i.e. 70.42%  of  tumors,
followed  by  tumors of  the  middle mediastinum  ,  which  form  21.12%
,i.e. 15 patients in 71 total patients. Superior mediastinum masses form
about 8.45% of the total patients.
SURGICAL APPROACHES
No. of Cases
Median Sternotomy 12
Mini Sternotomy 3
Right Anterolateral Thoracotomy 6
Left Anterolateral Thoracotomy 7
Right Posterolateral Thoracotomy 6
Left Posterolateral Thoracotomy 19
Right Anterior Thoracotomy 6
Left Anterior Thoracotomy 6
FOB – Biopsy 4
CT – Biopsy 1
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Of the surgical approaches used in the treatment of  the patients,
thoracotomy was the  most commonly used  approach amounting to  50
out of the 71 patients, i.e. 70.42%. Of all the thoracotomy approaches,
Left Posterolateral   approach   was the   most   common approach.
Sternotomy  was  used  in  12  patients,  i.e. 16.9%.  Ministernotomy  was
done in3 patients and endoscopic biopsy was done for 4 patients.
SURGICAL PROCEDURE
No. of Patients
FOB 5.6
CT GUIDED 1.4
OPEN BIOPSY 8.4
EXCISION BIOPSY 77.46
DEBULKING 6.4
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Among  the  total  patients,  majority  were  treated  with  excision
biopsy.  Of the remaining  patients, 6 underwent  open biopsy,  5
underwent  debulking,  4  were  biopsied  treated  endoscopically,  and 1
patient were treated under CT guidance.
DISTRIBUTION OF MEDIASTINAL TUMORS
Tumor Type No. of Cases
Thymic tumors 18
Cystic lesions 8
Neurogenic tumors 8
Germ cell tumors 8
Lymphomas 4
Oesophageal lesions 2
Pleural lesions 2
FOB 4
Others 15
Specimen inconclusive 2
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DISTRIBUTION OF THYMIC TUMOURS
Pathological Diagnosis No: of Cases
Thymoma 7
Thymic Lymphoma 2
Thymic Carcinoma 1
Other anomalous lesions 3
Thymic Follicular Hyperplasia 5
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Thymic  masses  consisted  of  18  patients  (  25.35%)  .  Of  the
thymic   tumors,  38.89%   were thymomas,   11.1% were   tthymic
lymphomas, 1 patient  had thymic carcinoma,  i.e.  0.6%.  Of  the
remaining patients,  16.66%  had miscellaneous anomalous lesions and
27.78% had thymic follicular hyperplasia.
THYMIC TUMORS
No. of patients
With myasthenia 8
Without myasthenia 10
No. of patients
Benign 17
Malignant 1
Among the 8 patients with myasthenia gravis , 6 patients required
4 cycles of   plasmapheresis   preoperatively and   4 cycles   of
plasmapheresis  postoperatively  followed  by  tablet pyridostigmine,  2
patients did not require plasmapheresis
CYSTIC LESIONS
No. of Cases
Collagenous fibrous cyst 1
Branchial cyst 3
Lymph cyst 1
Hydatid Cyst 2
Granulation Cyst 1
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Cystic lesions formed 11.26% of the total number of patients (8
of 71 patients). Of  these branchial cysts were diagnosed  in 3 patients,
hydatid cyst in 2 patients, granulation cyst and lymph cyst in 1 patient
each .
NEUROGENIC TUMOURS
No. of Cases
Schwannoma 4
Neurofibroma 4
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Of  the  71  patients,  8  patients  were  diagnosed  with  neurogenic
tumours.  Of these  neurogenic tumours,  50 %  were  schwannomas and
remaining 50% were neurofibromas
GERM CELL TUMOURS
No: of Cases
Mature teratoma 7
Immature teratoma 1
Germ  cell  tumors  were  diagnosed  in  8  patients  of  the  total  71
patients. Of these patients, 7 patients had mature teratomas, i.e. 87.5%
and the remaining 1 patient had immature teratoma forming 12.5%.
LYMPHOMAS
No. of patients
Hodgkins Lymphoma 2
Non-Hodgkins Lymphoma 2
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Immunohistochemistry  was  done  for  the  2  NHL  patients.  The
first  patient’s  report  showed  CD3-ve,CT20-positive,  CT45-  positive.
(Large Cell NHL). The  second patient (Atypical B cell proliferation )
showed CD20, CD799 positive. CD3, CIL, CD43 negative. KI Index 10
to 15%.
Thymic  tumors were found predominantly in anterior
compartment (15  out of  18). Teratomas  were  present in  (anterior 3,
middle  2,  posterior   2,  superior   1),   the  commonest  being   anterior
compartment. Neurogenic tumors  were found exclusively  in the
posterior  compartment  (8  out  of  8).  Cystic  lesions  were  found
predominantly in the middle compartment (7 out of 8).
FOB LESIONS
No. of Cases
Inconclusive Right Bronchial 2
Lesion
Necrotic Material 1
Inconclusive Left Bronchial 1
Lesion
Of   the  patients  managed   endoscopically,   2   patients  had   an
inconclusive  right bronchial lesion  (50%), 1  patient  had  inconclusive
left bronchial lesion  (25%)  and the remaining 1  patient had  necrotic
material (25%).
PLEURAL LESIONS
No. of Cases
Sarcoma 1
Fibroma 1
OESOPHAGEAL LESIONS
NO: OF CASES
MOD DIFF KERATINIZED SCC 1
SCC MOD DIFF 1
SPECIMEN INCONCLUSIVE – 2 CASES
In  the  remaining  patients  having  miscellaneous  lesions,  pleural
lesions were found in 2 patients, 1 patient being diagnose with pleural
sarcoma and the other with pleural fibroma. 2 patients were diagnosed
with oesophageal problems, 1 being   moderately differentiated
squamous cell carcinoma and the other being moderately differentiated
keratinized  squamous cell carcinoma.  2  patients  were  diagnosed  with
inconclusive specimens.
OTHER LESIONS
1) Anterior mediastinal mass – Benign angiomatous lesion
2) Superior mediastinal mass – Chondrosarcoma rib left side ( HIV
positive)
3) Posterior mediastinal mass – Chondroma right side
4) Anterior mediastinal mass – Fibrofatty tissue
5) Anterior mediastinal mass – Fibromatosis
6) Posterior mediastinal mass – Fibrofatty tissue
7) Superior mediastinal mass – Fibroalveolar pattern
8) Superior mediastinal mass – Fibrovascular tissue
9) Posterior  mediastinal mass –  Fibrous tissue with infiltrative cell
necrosis
10) Superior   mediastinal mass   – Low   grade   mucoepidermoid
carcinoma
Discussion
This study  on  mediastinal tumors was based  on a  total  patient
strength of 71 patients. Patients age varied from the 1st decade of life to
the  8th decade.  In comparison, Ho  et al study  was based  on  a total of
128 patients whose age ranged from 4 to 72 years, Nandi et al based a
study on 74 patients and  Velit Halit on a  strength of 20 patients.  The
age  range of the study by Velit Halit was from  2  years  to  55  years,
while Nandi et al study had patients’ mean age of 32 years. Herlitzka et
al study involved 159 patients, Morrison et al included 289 patients, Le
Roux involved 105 patients, Boyd et al 96, Wychulis et al included 916
patients, Fontenelle et al 64 patients, Rubush et al 157 patients, Ovrum
et al 56 patients, Davis et al 354 patients and  Cohen et al 216 patients.
Of the total 71 patients, 39 were male patients and the remaining
32 were female patients in the present study. In the Ho et al study of a
total of  128 patients, 70 were male patients while the  remaining 58
patients were  females. And  in the Nandi et al study , of  a total of 71
patients, 43 were male and 31 were female patients.
The  total  of 71  patients had  mediastinal masses involving all
compartments of  the mediastinum. On subdivision of  thte masses into
the separate compartments, it was found that 25 patients had masses in
the anterior mediastinum i.e. 35.21% , 6 patients had masses in superior
mediastinum  i.e.  8.4%, while  15  patients  had masses  in  the middle
mediastinum  (21.12%) and the remaining 25  (35.21%) patients had
posterior mediastinal masses. In comparison, Velit Halit study included
7 patients with anterior mediastinal masses (35%), 1 patient each with
masses in the  superior  and middle mediastinum  respectively, and  the
majority of patients i.e. 11  patients (55%) with  posterior  mediastinal
masses.  In the Ho  et al study, 81  patients of the total 128 patients (
63.3%) had anterosuperior masses, 15 patients ( 11.7%) had masses in
the  middle  mediastinum  and  the  remaining  32  patients  (25%)  had
posterior mediastinal masses.
In the Velit Halit study, 11 patients presented asymptomatically,
while  30  patients  presented  asymptomatically  in  Nandi  et  al  study
compared with 27 patients in the present study (38.02%)
Presenting symptoms ranged  from  cough, pain and dyspnoea to
dysphagia, hemoptysis and  myasthenia.  The  commonest symptom in
the present study was cough which was seen in 36.61%, pain in 18.30%
, while in the Davis et al study 60%   of patients presented with cough
and 30% presented  with  pain  and  discomfort.  In  the  Ho  et  al  study,
28.9% presented with cough and 21.2% presented with pain.. Dyspnoea
was present  in 5.63%  of  patients in  the  present  study  compared  with
28.9% in the  Ho et al study. Dysphagia was a minor symptom  in the
present study, being present in 2.8% of patients, and 2.3 % in Ho et al
study,  in contrast to Davis et al  study which  showed  16%  of patients
presenting  with  dysphagia.  20% of patients in  the  Davis  et  al  study
presented  with  fever and  chills,  while  3%  patients had  palpitations,
6.25%  had  SVC  syndrome  manifestations  in  the   Ho   et  al  study.
Myasthenia as a major symptom, was seen in 38.03% of patients in the
present study.
On  the  pathological  classification  of  the  mediastinal masses,  it
was  found  that  8  patients  had  neurogenic  tumors  (11.26%),  while
comparing with previous studies which had neurogenic tumors in 22%
in the Herlitzka et al study, 34.95% in the Morrison et al study, 28.57%
in the Le Roux study,  11.46% in Boyd et al study, 23.14% in Wychulis
study,  10.97%  in  Fontenelle  study,  22.93%  in  Rubush  et  al  study,
33.92%  in Ovrum  et  al study, 16.1% in Davis et  al study,  18.05% in
Cohen et al, 36.49% in Nandi  et al study and 22.6% in Ho et al study.
In the Duwe et al study, germ cell tumors made of 15% of the patients,
cysts formed 12 to 20% of which 50 to 70 % were enterogenous cysts,
7  to 15%  consisted  of bronchogenic  cysts.  Of  the total, 12  to  21  %
formed neurogenic tumors. In the Strollo et al study, 60% consisted of
neurogenic tumors, thymomas and benign cysts while 30% consisted of
lymphomas,  teratomas  and  granulomatous  masses.  Vascular  lesions
formed  10% of  the strength in  Strollo  et al study. In  comparison,
Cystic lesions formed 11.26% of the total number of patients (8 of 71
patients). Of these branchial cysts were diagnosed in 3 patients, hydatid
cyst in 2 patients, granulation cyst and lymph cyst in 1 patient each.
Of   the  patients  managed   endoscopically,   2   patients  had   an
inconclusive  right bronchial lesion  (50%), 1  patient  had  inconclusive
left bronchial lesion (25%) and the  remaining 1  patient had  necrotic
material (25%).
Thymic tumors formed about 35.21% in the present study, while
they formed 8.8% in Herlitzka et al study, 16.26% in Morrison  study,
16.19% in the Le Roux study, 20.83% in Boyd et al study, 24.56% in
Wychulis et al  study, 28.12%  in  Fontenelle  et al  study, 32.48% in
Rubush et al study, 17.85% in Ovrum et al study, 18.93% in Davis et al
study, 20.83%  in Cohen et al  study, 28.37%  in Nandi  et al  study  and
37% in Ho et al study.
Lymphomas were present in 2.8% in the study population i.e. 2
patients, while in comparison Herlitzka et al showed 7.5% lymphomas,
Morrison et al 11.41%, 20.83% in Boyd et al, 11.68% in Wychulis et al
study, 21.87% in Fontenelle et al study, 8.91%  in Rubush et al study,
16.07%  in Ovrum  and  Birkeland  study, 17.51%  in Davis et  al study,
16.66% in Cohen et al study 5.4% in Nandi et al study and 17% in Ho
et  al  study.  Interestingly  in  the  Le  Roux  et  al  study  no  cases  of
mediastinal lymphoma was recorded. Germ cell tumors formed 11.26%
in the present study  compared with 16.35%  in Herlitzka et al study,
12.45% in the Morrison et al study, 20% in Le Roux study, 22.92% in
Boyd et al study, 10.8% in Wychulis et al study, 4.6% in Fontenelle et
al study, 8.91% in Rubush et al study, 8.9% in Ovrum study, 11,8% in
Davis et al study, 9.4% by Nandi et al and 22% in Ho et al study.
The  remaining  of  the  mediastinal  masses were formed of
enterogenous cysts, pericardial cysts and other lesser common varieties.
On analysis of  the surgical approaches, it was observed that the
most common approach used was the Left Posterolateral thoracotomy
which  comprised  26.76%  of  the  study  population,  while  the  next
common approach was the median sternotomy approach used in 16.9%.
The division of the other approaches was  as follows,  4.2% underwent
mini sternotomy, 8.4% had right anterolateral approach, 9.8% had Left
Anterolateral approach and  Right Posterolateral approach  in 8.4%  of
patients. Of  the remaining patients,  8.4% had  Right and  Left  anterior
thoracotomy and endoscopic management  in 5.6 %. In  comparison,
Velit  Halit  et  al  study  showed  50%  had Right thoracotomy  approach,
while Left thoracotomy and sternotomy was done in 15% each.
Summary
& Conclusion
The  mediastinum,  an  important  compartment  of  the  thoracic
cavity, is the site for many cystic and tumoral lesions of various tissues.
Since  it contains various  vital organs  that could  be  compromised  by
such  lesions,  early  diagnosis  and   appropriate   treatment  should  be
performed as soon as possible. However, the evaluation and treatment
of mediastinal masses continue to present challenging problems to the
surgeons. Recent advances in diagnostic techniques and the availability
of multimodality treatment   regimens subsequent   to surgery  have
enabled better therapeutic outcomes.
Primary mediastinal tumors and cysts are common in young and
middle   aged patients.   Most   masses are   discovered on routine
radiographic examinations in asymptomatic patients, but many lesions
produce non-specific clinical manifestations. Approximately two thirds
of  patients have symptoms  at  time of presentation.  The  absence of
symptoms is a  reasonably  good  indicator that the tumor may be  of
benign origin.
Advances  in imaging  technology,  radioisotopic improvement in
cytology  techniques  and  the  introduction  of  radioimmunoassay,  have
enhanced  the ability to  assess  more precisely the anatomic  extent and
the type of mediastinal mass. CT guided needle biopsy may be valuable
in the verification of malignancy in about 80 to 90 % of cases.
A proper evaluation should be done to determine the location and
extension of the lesion. Since compression of the vital organs may be a
significant  risk, early  diagnosis  and proper  surgical removal  are
mandatory . Mediastinoscopy may be  necessary to  make  a diagnosis
and respectability in this  sense.  Also  novel approaches in anesthesia  ,
surgical techniques, postoperative care, chemotherapy, immunotherapy
and  radioitherapy  have  improved  mortality  and  morbidity,  increasing
survival and quality of life.
On  overview  of  this  study  revealed  that  out  of  the  71  cases
studied, thymic tumors was diagnosed in18 cases, various cystic lesions
in 8 cases, neurogenic lesions in 8 cases, tumors of germ  cell  origin
form 8 cases, lymphomas in 4, esophageal and pleural lesions 2 in each.
In  this  study  postoperative  morbidity  were  encountered  in  5  cases.
1 case of peroperative mortality. Among the postoperative morbidity, 2
cases  were  reopened on the  day of surgery for  bleeding , 4  cases had
postoperative  wound  dehiscence  which  were  treated  appropriately. 9
cases  were  referred  for  radiotherapy  and  chemotherapy  for  further
management  of   the  disease.  Thymic  tumor  cases  associated   with
myasthenia  gravis  (8)  were  treated  preoperatively  with  4  cycles  of
plasmapheresis followed by surgery and postoperatively by 4 cycles of
plasmapheresis  and  tablet  pyridostigmine  was  given.  Patients  were
followed up in  the neuro-medicine department.  Overall analysis
revealed benign mediastinal lesions in 59 and malignant in 8, specimen
inconclusive in 8  cases. Among  the benign lesions 51 cases had  solid
tumors while 8 patients had cystic lesions.
Proforma
PROFORMA
Patient Name, Age Sex :
M.R.D. No. :
Address, Occupation :
Consultant in charge unit :
D.O.A. :
D.O.S. :
D.O.D. :
Chief Complaints :
Neurologic Symptoms :
Caridiac Symptoms :
Constitutional Symptoms : Fever : Weigh Loss :
Pain :
Past History :
Family History :
General Examination : Pallor :
Cyanosis :
Ptosis :
Jaundice :
Pedal edema :
P.R./ B.P. :
Systemic Examination :       CVS
        RS
Neurologic Examination :
Investigation : Hb, PCV, ESR
        ECG
        CXR
CT Chest
        MRI
        FOB
Endoscopy
Diagnosis :
Surgical Procedure :
Approach : R.ALT, L.ALT, MS,
L.PLT, R.PLT
R.AT, L.AT, MiS
Tumor Location, Size :
Post operative outcome :
Complication : Morbidity, Mortality
Adjuvant Therapy : CT, RT, Plasmapheresis
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